Sanford C. Bernstein
https://www.bernsteinresearch.comSanford C. Bernstein, a division of AllianceBernstein, is a research firm.
View Older Stories View More Recent Stories
-
TANDEM DIABETES CARE, INC. (NASDAQ: TNDM) DEADLINE ALERT: Bernstein Liebhard LLP Announces that a Securities Class Action Lawsuit Has Been Filed Against Tandem Diabetes Care, Inc.
-
LESLIE’S, INC. (NASDAQ: LESL) DEADLINE ALERT: Bernstein Liebhard LLP Announces that a Securities Class Action Lawsuit Has Been Filed Against Leslie’s, Inc.
-
MASIMO CORPORATION (NASDAQ: MASI) DEADLINE ALERT: Bernstein Liebhard LLP Reminds Investors of the Deadline to File a Lead Plaintiff Motion in a Securities Class Action Lawsuit Against Masimo Corporati
-
DIGITALOCEAN HOLDINGS, INC. (NYSE: DOCN) DEADLINE ALERT: Bernstein Liebhard LLP Reminds Investors of the Deadline to File a Lead Plaintiff Motion in a Securities Class Action Lawsuit Against DigitalOc
-
AEROVIRONMENT, INC. (NASDAQ: AVAV) DEADLINE ALERT: Bernstein Liebhard LLP Reminds Investors of the Deadline to File a Lead Plaintiff Motion in a Securities Class Action Lawsuit Against AeroVironment,
-
ENVIVA, INC. (NYSE: EVA) DEADLINE ALERT: Bernstein Liebhard LLP Reminds Investors of the Deadline to File a Lead Plaintiff Motion in a Securities Class Action Lawsuit Against Enviva, Inc.
-
BAUSCH HEALTH COMPANIES INC. (NYSE: BHC) DEADLINE ALERT: Bernstein Liebhard LLP Reminds Investors of the Deadline to File a Lead Plaintiff Motion in a Securities Class Action Lawsuit Against Bausch He
-
PACWEST BANCORP (NASDAQ: PACW) DEADLINE ALERT: Bernstein Liebhard LLP Reminds Investors of the Deadline to File a Lead Plaintiff Motion in a Securities Class Action Lawsuit Against PacWest Bancorp
-
HAYWARD HOLDINGS, INC. (NYSE: HAYW) DEADLINE ALERT: Bernstein Liebhard LLP Reminds Investors of the Deadline to File a Lead Plaintiff Motion in a Securities Class Action Lawsuit Against Hayward Holdin
-
INTEGRA LIFESCIENCES HOLDING CORPORATION (NASDAQ: IART) DEADLINE ALERT: Bernstein Liebhard LLP Reminds Investors of the Deadline to File a Lead Plaintiff Motion in a Securities Class Action Lawsuit Ag
-
RTX CORPORATION (NYSE: RTX) DEADLINE ALERT: Bernstein Liebhard LLP Reminds Investors of the Deadline to File a Lead Plaintiff Motion in a Securities Class Action Lawsuit Against RTX Corporation f/k/a
-
APELLIS PHARMACEUTICALS, INC. (NASDAQ: APLS) DEADLINE ALERT: Bernstein Liebhard LLP Reminds Investors of the Deadline to File a Lead Plaintiff Motion in a Securities Class Action Lawsuit Against Apell
-
APPLIED DIGITAL CORPORATION (NASDAQ: APLD) DEADLINE ALERT: Bernstein Liebhard LLP Reminds Investors of the Deadline to File a Lead Plaintiff Motion in a Securities Class Action Lawsuit Against Applied
-
Valor PayTech Appoints Daniel O’Connell- Payments and Fintech Veteran as new Chief Financial Officer
-
VistaJet announces new partnership with maverick Burgundy winemaker Olivier Bernstein
-
Sosei Heptares Adds World-leading Expertise to its Scientific Advisory Board
-
Quality Jobs Fund and Kresge Foundation Invests Millions in The 22 Fund for Climate Justice
-
DEMI LOVATO BRINGS POWERFUL MESSAGE TO #GXC2023: DISCOVER WHO YOU ARE MEANT TO BE
-
Rachael Sage Releases Unforgettable Video for Heartfelt Song 'No Regrets'
-
Rachael Sage Releases Unforgettable Video for Heartfelt Song 'No Regrets'
-
Arm shares post third daily loss with IPO buzz fizzling, short sellers hovering
-
Arm Holdings shares slide as options draw robust trading volume
-
'Too soon' to declare Arm Holdings (ARM) an AI winner says Bernstein
-
'Be like Buffett' when it comes to Apple (AAPL) stock says Bernstein. Here's how
-
Markforged Unlocks The Future Of Distributed Manufacturing, Enabling Manufacturer-Certified Parts To Be Licensed And Printed At The Point Of Need
-
Bernstein Starts Arm Holdings (ARM) at Underperform, The AI Arm Twist'
-
Bernstein discusses Bull vs. Bear case on Apple (AAPL)
-
Wall Street moves sideways as investors look to Fed
-
PACWEST BANCORP SHAREHOLDER ALERT: Bernstein Liebhard LLP Announces that a Securities Class Action Lawsuit Has Been Filed Against PacWest Bancorp (NASDAQ: PACW)
-
ENVIVA, INC. SHAREHOLDER ALERT: Bernstein Liebhard LLP Announces that a Securities Class Action Lawsuit Has Been Filed Against Enviva, Inc. (NYSE: EVA)
-
INTEGRA LIFESCIENCES HOLDING CORPORATION SHAREHOLDER ALERT: Bernstein Liebhard LLP Announces that a Securities Class Action Lawsuit Has Been Filed Against Integra LifeSciences Holding Corporation (NAS
-
DIGITALOCEAN HOLDINGS, INC. SHAREHOLDER ALERT: Bernstein Liebhard LLP Announces that a Securities Class Action Lawsuit Has Been Filed Against DigitalOcean Holdings, Inc. (NYSE: DOCN)
-
Instacart (CART) raises IPO pricing after successful ARM debut; Valuation 'reasonable' says analyst
-
NMHC Announces New Initiative to Support Residents at White House Meeting
-
Frequency Electronics, Inc. Announces First Quarter Fiscal Year 2024 Financial Results
-
Form 4 ACCO BRANDS Corp For: Sep 12 Filed by: Bernstein Roxanne M
-
Russia expels two US embassy staff for 'illegal activity'
-
Adobe Systems (ADBE) gains as analysts weigh in positively on new AI pricing
-
German carmaker stocks dip amid China-EV probe dispute
-
US contacts oil producers, refiners as gasoline prices rise
-
Biden wants UAW, automakers to work around-the-clock to avert strike
-
Optilogic Defies Market Dynamics to Secure New Funding and Investment Partners
-
UAW preparing to strike at Detroit Three automakers, rejects new offers
-
Oil dips as surprise US crude stockbuild faces supply cuts
-
Birkenstock Announces Filing of Registration Statement for Proposed Public Offering
-
Frequency Electronics Announces 1st Quarter Financial Results Conference Call: Thursday September 14, 2023, at 4:30 PM ET
-
Infleqtion Unveils Open Beta Release of Superstaq: Accelerating Quantum Computing Performance
-
Brightside Health Expands Executive Leadership Team with Julia Bernstein, Chief Operations Officer
-
2seventy bio (TSVT) and JW Therapeutics To Expand Strategic Partnership to Accelerate the Research and Development of T Cell-based Immunotherapies and Autoimmune Therapies
-
2seventy bio and JW Therapeutics Announce Intent To Expand Strategic Partnership to Accelerate the Research and Development of T Cell-based Immunotherapies and Autoimmune Therapies
